ACHV logo

Achieve Life Sciences (ACHV) Working Capital

Annual Working Capital

-$3.83 M
-$9.56 M-166.85%

31 December 2023

ACHV Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$38.81 M
-$10.00 M-20.49%

30 September 2024

ACHV Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ACHV Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-166.8%+117.9%
3 y3 years-111.3%+22.6%
5 y5 years-131.2%+762.5%

ACHV Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-109.6%at low-20.5%+1113.1%
5 y5 years-109.6%at low-20.5%+1113.1%
alltimeall time-105.6%+44.5%-53.6%+484.3%

Achieve Life Sciences Working Capital History

DateAnnualQuarterly
Sept 2024
-
$38.81 M(-20.5%)
June 2024
-
$48.82 M(+3.6%)
Mar 2024
-
$47.14 M(-1330.4%)
Dec 2023
-$3.83 M(-166.8%)
-$3.83 M(-121.5%)
Sept 2023
-
$17.82 M(-22.3%)
June 2023
-
$22.93 M(-1204.1%)
Mar 2023
-
-$2.08 M(-136.2%)
Dec 2022
$5.73 M(-85.7%)
$5.73 M(-59.2%)
Sept 2022
-
$14.04 M(-45.6%)
June 2022
-
$25.79 M(-23.4%)
Mar 2022
-
$33.68 M(-15.9%)
Dec 2021
$40.04 M(+17.6%)
$40.04 M(+26.5%)
Sept 2021
-
$31.66 M(-16.2%)
June 2021
-
$37.76 M(+40.3%)
Mar 2021
-
$26.92 M(-20.9%)
Dec 2020
$34.04 M(+135.3%)
$34.04 M(+53.2%)
Sept 2020
-
$22.21 M(+104.8%)
June 2020
-
$10.85 M(-4.5%)
Mar 2020
-
$11.36 M(-21.5%)
Dec 2019
$14.46 M(+17.9%)
$14.46 M(+221.4%)
Sept 2019
-
$4.50 M(-42.4%)
June 2019
-
$7.81 M(+19.6%)
Mar 2019
-
$6.53 M(-46.8%)
Dec 2018
$12.27 M(+214.9%)
$12.27 M(+16.2%)
Sept 2018
-
$10.56 M(-17.6%)
June 2018
-
$12.81 M(+427.7%)
Mar 2018
-
$2.43 M(-37.7%)
Dec 2017
$3.90 M(-227.5%)
$3.90 M(-38.1%)
Sept 2017
-
$6.29 M(-50.5%)
June 2017
-
$12.71 M(-17.8%)
Mar 2017
-
$15.47 M(-606.4%)
Dec 2016
-$3.06 M(-108.3%)
-$3.06 M(-112.9%)
Sept 2016
-
$23.71 M(-13.8%)
June 2016
-
$27.52 M(-17.7%)
Mar 2016
-
$33.45 M(-8.7%)
Dec 2015
$36.63 M(+9.2%)
$36.63 M(-4.2%)
Sept 2015
-
$38.25 M(+38.0%)
June 2015
-
$27.71 M(-5.3%)
Mar 2015
-
$29.27 M(-12.7%)
Dec 2014
$33.54 M(-13.8%)
$33.54 M(-16.9%)
Sept 2014
-
$40.39 M(+45.9%)
June 2014
-
$27.68 M(-11.4%)
Mar 2014
-
$31.25 M(-19.7%)
Dec 2013
$38.93 M(-43.3%)
$38.93 M(-14.1%)
Sept 2013
-
$45.34 M(-16.9%)
June 2013
-
$54.56 M(-12.6%)
Mar 2013
-
$62.45 M(-9.0%)
Dec 2012
$68.62 M(+89.8%)
$68.62 M(-7.4%)
Sept 2012
-
$74.14 M(-4.4%)
June 2012
-
$77.53 M(-7.3%)
Mar 2012
-
$83.60 M(+131.2%)
Dec 2011
$36.16 M(-41.5%)
$36.16 M(-34.1%)
Sept 2011
-
$54.85 M(+7.7%)
June 2011
-
$50.95 M(-12.6%)
Mar 2011
-
$58.30 M(-5.7%)
Dec 2010
$61.84 M(+45.1%)
$61.84 M(+83.4%)
Sept 2010
-
$33.73 M(-10.3%)
June 2010
-
$37.62 M(-0.3%)
Mar 2010
-
$37.72 M(-11.5%)
DateAnnualQuarterly
Dec 2009
$42.62 M(+275.0%)
$42.62 M(+264.8%)
Sept 2009
-
$11.68 M(+160.0%)
June 2009
-
$4.49 M(-50.4%)
Mar 2009
-
$9.06 M(-20.3%)
Dec 2008
$11.37 M(-60.6%)
$11.37 M(-29.3%)
Sept 2008
-
$16.08 M(-26.2%)
June 2008
-
$21.79 M(-13.4%)
Mar 2008
-
$25.18 M(-12.8%)
Dec 2007
$28.86 M(-38.5%)
$28.86 M(+3.8%)
Sept 2007
-
$27.79 M(-23.5%)
June 2007
-
$36.32 M(-15.4%)
Mar 2007
-
$42.94 M(-8.5%)
Dec 2006
$46.94 M(+3.2%)
$46.94 M(-14.4%)
Sept 2006
-
$54.86 M(-12.1%)
June 2006
-
$62.40 M(+57.8%)
Mar 2006
-
$39.54 M(-13.0%)
Dec 2005
$45.47 M(+155.7%)
$45.47 M(+151.7%)
Sept 2005
-
$18.06 M(+94.7%)
June 2005
-
$9.28 M(-29.4%)
Mar 2005
-
$13.14 M(-26.1%)
Dec 2004
$17.78 M(+0.1%)
$17.78 M(-22.3%)
Sept 2004
-
$22.90 M(-13.5%)
June 2004
-
$26.46 M(+74.1%)
Mar 2004
-
$15.20 M(-14.5%)
Dec 2003
$17.77 M(+21.0%)
$17.77 M(-10.0%)
Sept 2003
-
$19.74 M(+116.5%)
June 2003
-
$9.12 M(-25.6%)
Mar 2003
-
$12.26 M(-16.5%)
Dec 2002
$14.69 M(+2.9%)
$14.69 M(-13.7%)
Sept 2002
-
$17.02 M(-16.3%)
June 2002
-
$20.35 M(-15.6%)
Mar 2002
-
$24.11 M(+68.9%)
Dec 2001
$14.27 M(+78.2%)
$14.27 M(-9.4%)
Sept 2001
-
$15.75 M(+54.7%)
June 2001
-
$10.18 M(+38.2%)
Mar 2001
-
$7.36 M(-8.1%)
Dec 2000
$8.01 M(-12.8%)
$8.01 M(+2.5%)
Sept 2000
-
$7.81 M(-21.0%)
June 2000
-
$9.89 M(+28.0%)
Mar 2000
-
$7.72 M(-15.9%)
Dec 1999
$9.19 M(+13.4%)
$9.19 M(+50.6%)
Sept 1999
-
$6.10 M(+52.5%)
June 1999
-
$4.00 M(-42.9%)
Mar 1999
-
$7.00 M(-13.6%)
Dec 1998
$8.10 M(-54.2%)
$8.10 M(-24.3%)
Sept 1998
-
$10.70 M(-14.4%)
June 1998
-
$12.50 M(-16.7%)
Mar 1998
-
$15.00 M(-15.3%)
Dec 1997
$17.70 M(+11.3%)
$17.70 M(+7.9%)
Sept 1997
-
$16.40 M(-6.8%)
June 1997
-
$17.60 M(+1.7%)
Mar 1997
-
$17.30 M(+8.8%)
Dec 1996
$15.90 M(+55.9%)
$15.90 M(+18.7%)
Sept 1996
-
$13.40 M(+27.6%)
June 1996
-
$10.50 M(+87.5%)
Mar 1996
-
$5.60 M(-45.1%)
Dec 1995
$10.20 M(-247.8%)
$10.20 M(-201.0%)
Sept 1995
-
-$10.10 M(+46.4%)
Dec 1994
-$6.90 M
-$6.90 M

FAQ

  • What is Achieve Life Sciences annual working capital?
  • What is the all time high annual working capital for Achieve Life Sciences?
  • What is Achieve Life Sciences annual working capital year-on-year change?
  • What is Achieve Life Sciences quarterly working capital?
  • What is the all time high quarterly working capital for Achieve Life Sciences?
  • What is Achieve Life Sciences quarterly working capital year-on-year change?

What is Achieve Life Sciences annual working capital?

The current annual working capital of ACHV is -$3.83 M

What is the all time high annual working capital for Achieve Life Sciences?

Achieve Life Sciences all-time high annual working capital is $68.62 M

What is Achieve Life Sciences annual working capital year-on-year change?

Over the past year, ACHV annual working capital has changed by -$9.56 M (-166.85%)

What is Achieve Life Sciences quarterly working capital?

The current quarterly working capital of ACHV is $38.81 M

What is the all time high quarterly working capital for Achieve Life Sciences?

Achieve Life Sciences all-time high quarterly working capital is $83.60 M

What is Achieve Life Sciences quarterly working capital year-on-year change?

Over the past year, ACHV quarterly working capital has changed by +$21.00 M (+117.87%)